Annual Operating Profit
-$52.80 M
+$2.93 M+5.26%
September 30, 2024
Summary
- As of February 22, 2025, AVXL annual operating income is -$52.80 million, with the most recent change of +$2.93 million (+5.26%) on September 30, 2024.
- During the last 3 years, AVXL annual operating profit has fallen by -$10.85 million (-25.87%).
- AVXL annual operating profit is now -364051.72% below its all-time high of -$14.50 thousand, reached on September 30, 2004.
Performance
AVXL Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$13.58 M
+$681.00 K+4.78%
December 31, 2024
Summary
- As of February 22, 2025, AVXL quarterly operating income is -$13.58 million, with the most recent change of +$681.00 thousand (+4.78%) on December 31, 2024.
- Over the past year, AVXL quarterly operating profit has increased by +$681.00 thousand (+4.78%).
- AVXL quarterly operating profit is now -331119.51% below its all-time high of -$4100.00, reached on December 31, 2004.
Performance
AVXL Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$54.62 M
-$2.20 M-4.20%
December 31, 2024
Summary
- As of February 22, 2025, AVXL TTM operating income is -$54.62 million, with the most recent change of -$2.20 million (-4.20%) on December 31, 2024.
- Over the past year, AVXL TTM operating profit has dropped by -$2.20 million (-4.20%).
- AVXL TTM operating profit is now -1332021.95% below its all-time high of -$4100.00, reached on December 31, 2004.
Performance
AVXL TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
AVXL Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.3% | +4.8% | -4.2% |
| 3 y3 years | -25.9% | +4.8% | -4.2% |
| 5 y5 years | -83.3% | +4.8% | -4.2% |
AVXL Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -25.9% | +5.3% | -19.4% | +11.6% | -23.4% | +5.2% |
| 5 y | 5-year | -83.3% | +5.3% | -80.9% | +11.6% | -90.5% | +5.2% |
| alltime | all time | <-9999.0% | +5.3% | <-9999.0% | +11.6% | <-9999.0% | +5.2% |
Anavex Life Sciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$13.58 M(-4.8%) | -$54.62 M(+4.2%) |
| Sep 2024 | -$52.80 M(-5.3%) | -$14.26 M(-3.2%) | -$52.41 M(+3.2%) |
| Jun 2024 | - | -$14.73 M(+22.3%) | -$50.81 M(+2.4%) |
| Mar 2024 | - | -$12.05 M(+5.9%) | -$49.61 M(-2.7%) |
| Dec 2023 | - | -$11.38 M(-10.1%) | -$51.00 M(-7.2%) |
| Sep 2023 | -$55.73 M(+9.3%) | -$12.65 M(-6.5%) | -$54.98 M(-4.6%) |
| Jun 2023 | - | -$13.53 M(+0.7%) | -$57.61 M(+1.9%) |
| Mar 2023 | - | -$13.44 M(-12.5%) | -$56.54 M(+3.5%) |
| Dec 2022 | - | -$15.36 M(+0.5%) | -$54.62 M(+7.1%) |
| Sep 2022 | -$50.99 M(+21.5%) | -$15.28 M(+22.7%) | -$50.99 M(+6.3%) |
| Jun 2022 | - | -$12.46 M(+8.2%) | -$47.95 M(+2.4%) |
| Mar 2022 | - | -$11.52 M(-1.7%) | -$46.85 M(+5.8%) |
| Dec 2021 | - | -$11.72 M(-4.3%) | -$44.28 M(+5.5%) |
| Sep 2021 | -$41.95 M(+35.6%) | -$12.25 M(+7.9%) | -$41.95 M(+12.8%) |
| Jun 2021 | - | -$11.36 M(+27.0%) | -$37.20 M(+9.6%) |
| Mar 2021 | - | -$8.94 M(-4.8%) | -$33.95 M(+3.8%) |
| Dec 2020 | - | -$9.40 M(+25.2%) | -$32.71 M(+5.7%) |
| Sep 2020 | -$30.94 M(+7.4%) | -$7.51 M(-7.4%) | -$30.94 M(+4.2%) |
| Jun 2020 | - | -$8.11 M(+5.3%) | -$29.70 M(+3.6%) |
| Mar 2020 | - | -$7.70 M(+0.9%) | -$28.67 M(-1.3%) |
| Dec 2019 | - | -$7.63 M(+21.6%) | -$29.03 M(+0.8%) |
| Sep 2019 | -$28.81 M(+50.2%) | -$6.27 M(-11.3%) | -$28.81 M(+1.6%) |
| Jun 2019 | - | -$7.07 M(-12.3%) | -$28.35 M(+9.8%) |
| Mar 2019 | - | -$8.07 M(+9.0%) | -$25.82 M(+14.8%) |
| Dec 2018 | - | -$7.40 M(+27.3%) | -$22.49 M(+17.2%) |
| Sep 2018 | -$19.18 M(+23.5%) | -$5.81 M(+28.0%) | -$19.18 M(+3.4%) |
| Jun 2018 | - | -$4.54 M(-4.0%) | -$18.55 M(+5.1%) |
| Mar 2018 | - | -$4.73 M(+15.7%) | -$17.64 M(+6.9%) |
| Dec 2017 | - | -$4.09 M(-21.0%) | -$16.50 M(+6.2%) |
| Sep 2017 | -$15.54 M(+0.6%) | -$5.18 M(+42.4%) | -$15.54 M(-8.1%) |
| Jun 2017 | - | -$3.64 M(+1.2%) | -$16.92 M(+9.0%) |
| Mar 2017 | - | -$3.59 M(+14.6%) | -$15.53 M(+10.2%) |
| Dec 2016 | - | -$3.13 M(-52.2%) | -$14.09 M(-5.3%) |
| Sep 2016 | -$15.45 M(+117.3%) | -$6.56 M(+191.9%) | -$14.88 M(+21.1%) |
| Jun 2016 | - | -$2.25 M(+4.3%) | -$12.29 M(+6.3%) |
| Mar 2016 | - | -$2.15 M(-45.1%) | -$11.56 M(+12.6%) |
| Dec 2015 | - | -$3.92 M(-1.1%) | -$10.26 M(+44.3%) |
| Sep 2015 | -$7.11 M(+139.4%) | -$3.97 M(+162.2%) | -$7.11 M(+88.0%) |
| Jun 2015 | - | -$1.51 M(+76.3%) | -$3.78 M(+15.7%) |
| Mar 2015 | - | -$858.30 K(+11.4%) | -$3.27 M(-4.7%) |
| Dec 2014 | - | -$770.70 K(+20.5%) | -$3.43 M(+15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | -$2.97 M(+38.9%) | -$639.40 K(-36.0%) | -$2.97 M(-21.8%) |
| Jun 2014 | - | -$998.80 K(-2.2%) | -$3.80 M(+29.8%) |
| Mar 2014 | - | -$1.02 M(+229.8%) | -$2.93 M(+44.0%) |
| Dec 2013 | - | -$309.60 K(-78.9%) | -$2.03 M(-5.0%) |
| Sep 2013 | -$2.14 M(-50.5%) | -$1.47 M(+1065.4%) | -$2.14 M(+63.1%) |
| Jun 2013 | - | -$126.00 K(-0.9%) | -$1.31 M(-30.3%) |
| Mar 2013 | - | -$127.10 K(-69.4%) | -$1.88 M(-26.2%) |
| Dec 2012 | - | -$415.40 K(-35.2%) | -$2.55 M(-41.0%) |
| Sep 2012 | -$4.32 M(-30.1%) | -$641.40 K(-7.9%) | -$4.32 M(-11.9%) |
| Jun 2012 | - | -$696.30 K(-12.4%) | -$4.90 M(-16.1%) |
| Mar 2012 | - | -$794.70 K(-63.7%) | -$5.84 M(-16.5%) |
| Dec 2011 | - | -$2.19 M(+78.6%) | -$6.99 M(+13.3%) |
| Sep 2011 | -$6.17 M(+9.3%) | -$1.22 M(-25.1%) | -$6.17 M(-10.7%) |
| Jun 2011 | - | -$1.63 M(-16.0%) | -$6.91 M(+5.0%) |
| Mar 2011 | - | -$1.95 M(+42.3%) | -$6.58 M(+7.0%) |
| Dec 2010 | - | -$1.37 M(-30.4%) | -$6.15 M(+8.6%) |
| Sep 2010 | -$5.65 M(+19.3%) | -$1.96 M(+50.7%) | -$5.66 M(+3.0%) |
| Jun 2010 | - | -$1.30 M(-14.1%) | -$5.50 M(+0.8%) |
| Mar 2010 | - | -$1.52 M(+72.4%) | -$5.46 M(+15.9%) |
| Dec 2009 | - | -$880.00 K(-51.1%) | -$4.71 M(-0.5%) |
| Sep 2009 | -$4.73 M(-10.2%) | -$1.80 M(+43.3%) | -$4.73 M(-15.7%) |
| Jun 2009 | - | -$1.26 M(+63.2%) | -$5.62 M(+4.9%) |
| Mar 2009 | - | -$770.00 K(-15.0%) | -$5.36 M(+1.9%) |
| Dec 2008 | - | -$905.80 K(-66.3%) | -$5.26 M(-1.5%) |
| Sep 2008 | -$5.27 M(+234.0%) | -$2.69 M(+169.9%) | -$5.34 M(+40.7%) |
| Jun 2008 | - | -$995.00 K(+48.1%) | -$3.79 M(+24.2%) |
| Mar 2008 | - | -$671.70 K(-32.0%) | -$3.06 M(+19.7%) |
| Dec 2007 | - | -$987.50 K(-13.4%) | -$2.55 M(+61.8%) |
| Sep 2007 | -$1.58 M(+6063.7%) | -$1.14 M(+346.3%) | -$1.58 M(+256.5%) |
| Jun 2007 | - | -$255.60 K(+51.4%) | -$442.50 K(+129.8%) |
| Mar 2007 | - | -$168.80 K(+1272.4%) | -$192.60 K(+575.8%) |
| Dec 2006 | - | -$12.30 K(+112.1%) | -$28.50 K(+11.3%) |
| Sep 2006 | -$25.60 K(-72.1%) | -$5800.00(+1.8%) | -$25.60 K(-58.6%) |
| Jun 2006 | - | -$5700.00(+21.3%) | -$61.80 K(-39.3%) |
| Mar 2006 | - | -$4700.00(-50.0%) | -$101.80 K(-28.7%) |
| Dec 2005 | - | -$9400.00(-77.6%) | -$142.80 K(+3.9%) |
| Sep 2005 | -$91.70 K(+532.4%) | -$42.00 K(-8.1%) | -$137.50 K(+44.0%) |
| Jun 2005 | - | -$45.70 K(0.0%) | -$95.50 K(+91.8%) |
| Mar 2005 | - | -$45.70 K(+1014.6%) | -$49.80 K(+1114.6%) |
| Dec 2004 | - | -$4100.00 | -$4100.00 |
| Sep 2004 | -$14.50 K | - | - |
FAQ
- What is Anavex Life Sciences annual operating income?
- What is the all time high annual operating profit for Anavex Life Sciences?
- What is Anavex Life Sciences annual operating profit year-on-year change?
- What is Anavex Life Sciences quarterly operating income?
- What is the all time high quarterly operating profit for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly operating profit year-on-year change?
- What is Anavex Life Sciences TTM operating income?
- What is the all time high TTM operating profit for Anavex Life Sciences?
- What is Anavex Life Sciences TTM operating profit year-on-year change?
What is Anavex Life Sciences annual operating income?
The current annual operating profit of AVXL is -$52.80 M
What is the all time high annual operating profit for Anavex Life Sciences?
Anavex Life Sciences all-time high annual operating income is -$14.50 K
What is Anavex Life Sciences annual operating profit year-on-year change?
Over the past year, AVXL annual operating income has changed by +$2.93 M (+5.26%)
What is Anavex Life Sciences quarterly operating income?
The current quarterly operating profit of AVXL is -$13.58 M
What is the all time high quarterly operating profit for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly operating income is -$4100.00
What is Anavex Life Sciences quarterly operating profit year-on-year change?
Over the past year, AVXL quarterly operating income has changed by +$681.00 K (+4.78%)
What is Anavex Life Sciences TTM operating income?
The current TTM operating profit of AVXL is -$54.62 M
What is the all time high TTM operating profit for Anavex Life Sciences?
Anavex Life Sciences all-time high TTM operating income is -$4100.00
What is Anavex Life Sciences TTM operating profit year-on-year change?
Over the past year, AVXL TTM operating income has changed by -$2.20 M (-4.20%)